VELLORE CHRISTIAN MEDICAL COLLEGE FOUNDATION

VELLORE CMC FOUNDATION

Alumni in the News

New Jersey’s Only NCI-designated Comprehensive Cancer Center Names Director for Phase I Clinical Trials and Investigational Therapeutics

Enhancing its commitment to providing the most advanced treatment options for cancer patients through clinical trials, Rutgers Cancer Institute of New Jersey has named Sanjay Goel, MD, MS as director of its …

New Jersey’s Only NCI-designated Comprehensive Cancer Center Names Director for Phase I Clinical Trials and Investigational Therapeutics Read More »

Dr. Alok Srivastava Presents a Promising Experimental Hemophilia Therapy at the 63rd American Society of Hematology (ASH) Annual Meeting and Exposition

Fitusiran, an experimental hemophilia therapy administered through a monthly subcutaneous injection, met its primary endpoint in a phase III trial being presented at the 63rd American Society of Hematology (ASH) …

Dr. Alok Srivastava Presents a Promising Experimental Hemophilia Therapy at the 63rd American Society of Hematology (ASH) Annual Meeting and Exposition Read More »

Dr. Preman Singh (MBBS batch of 1983) Awarded the Peter Beaconsfield Runner-up Prize in Molecular Genetics at Oxford University in the Department of Physiology, Anatomy and Genetics (DPAG).

The Wilson Group – the assessors of the Peter Beaconsfield Prize have awarded Dr. Preman Singh the £250 Runner-up Prize. The prize is intended to reward young researchers who are …

Dr. Preman Singh (MBBS batch of 1983) Awarded the Peter Beaconsfield Runner-up Prize in Molecular Genetics at Oxford University in the Department of Physiology, Anatomy and Genetics (DPAG). Read More »